Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,138 | 412 | 99.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.47 | 1 | 0.3% |
| Education | $12.18 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $958.67 | 71 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $556.33 | 37 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $491.99 | 33 | $0 (2022) |
| Allergan, Inc. | $376.24 | 34 | $0 (2022) |
| Celgene Corporation | $368.22 | 15 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $285.96 | 16 | $0 (2023) |
| SK Life Science, Inc. | $222.62 | 11 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $216.35 | 13 | $0 (2024) |
| Lundbeck LLC | $211.50 | 14 | $0 (2023) |
| Biogen, Inc. | $208.04 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.94 | 1 | ACADIA Pharmaceuticals Inc ($17.94) |
| 2023 | $1,368 | 81 | ABBVIE INC. ($343.02) |
| 2022 | $1,486 | 104 | ABBVIE INC. ($387.75) |
| 2021 | $986.28 | 60 | AbbVie Inc. ($179.07) |
| 2020 | $331.24 | 21 | Allergan, Inc. ($66.90) |
| 2019 | $603.21 | 43 | Sunovion Pharmaceuticals Inc. ($138.62) |
| 2018 | $831.49 | 64 | Allergan Inc. ($147.17) |
| 2017 | $542.83 | 40 | Biogen, Inc. ($113.01) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/29/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Neuroscience | ||||||
| 10/12/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Neuroscience | ||||||
| 09/15/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: Neuroscience | ||||||
| 08/15/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.66 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Neurology | ||||||
| 07/20/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: NEUROLOGY | ||||||
| 07/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/14/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: PAIN | ||||||
| 07/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/12/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Neurology | ||||||
| 07/10/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEUROLOGY | ||||||
| 06/28/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Neuropsychiatry | ||||||
| 06/27/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: NEUROLOGY | ||||||
| 06/27/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/23/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Rare Disease | ||||||
| 06/20/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: Neurology | ||||||
| 06/15/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 631 | 6,270 | $234,111 | $65,153 |
| 2022 | 19 | 1,188 | 14,832 | $571,295 | $157,618 |
| 2021 | 19 | 1,148 | 13,649 | $548,316 | $158,074 |
| 2020 | 19 | 1,240 | 14,832 | $563,333 | $161,687 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 5,597 | $103,545 | $27,116 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 348 | 389 | $55,923 | $19,729 | 35.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 11 | 11 | $10,846 | $2,958 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 50 | $9,780 | $2,873 | 29.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 15 | 19 | $7,290 | $1,952 | 26.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 22 | 22 | $8,816 | $1,923 | 21.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 26 | 27 | $7,032 | $1,838 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $10,800 | $1,763 | 16.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 27 | 28 | $4,642 | $1,201 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,172 | $1,198 | 23.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 37 | $3,589 | $1,050 | 29.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 22 | 22 | $4,268 | $1,036 | 24.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 13 | 14 | $2,408 | $515.84 | 21.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 32 | 13,396 | $247,826 | $57,829 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 461 | 676 | $99,372 | $39,739 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 99 | $22,869 | $8,352 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $30,336 | $8,094 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 93 | 93 | $25,110 | $6,920 | 27.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 21 | 21 | $20,706 | $5,660 | 27.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 55 | 55 | $23,540 | $5,160 | 21.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 62 | 63 | $16,884 | $4,464 | 26.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 18 | 41 | $17,589 | $3,828 | 21.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 55 | 86 | $8,342 | $2,479 | 29.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 16 | 16 | $10,928 | $2,391 | 21.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 54 | 56 | $9,408 | $2,218 | 23.6% |
About Dr. Christopher Mitchell, M.D
Dr. Christopher Mitchell, M.D is a Neurology healthcare provider based in Jackson, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932317880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Mitchell, M.D has received a total of $6,166 in payments from pharmaceutical and medical device companies, with $17.94 received in 2024. These payments were reported across 414 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($6,138).
As a Medicare-enrolled provider, Mitchell has provided services to 4,207 Medicare beneficiaries, totaling 49,583 services with total Medicare billing of $542,531. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Jackson, TN
- Active Since 05/21/2007
- Last Updated 09/06/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1932317880
Products in Payments
- BOTOX (Biological) $528.31
- ZEPOSIA (Drug) $459.78
- APTIOM (Drug) $432.22
- KESIMPTA (Drug) $388.17
- UBRELVY (Drug) $269.50
- NUPLAZID (Drug) $216.35
- QULIPTA (Drug) $202.87
- NURTEC ODT (Drug) $191.98
- RYTARY (Drug) $172.94
- ANDEXXA (Biological) $157.18
- Aimovig (Biological) $149.43
- TYSABRI (Biological) $147.42
- OCREVUS (Biological) $134.20
- DUOPA (Drug) $127.80
- BOTOX THERAPEUTIC (Biological) $105.60
- VYEPTI (Biological) $95.95
- Ponvory (Drug) $91.48
- VYVGART (Drug) $85.91
- Fycompa (Drug) $84.16
- Gamunex-C (Biological) $81.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Jackson
Wendell Helveston, Md, MD
Neurology — Payments: $862,844
Dr. John Wald, M.d, M.D
Neurology — Payments: $530,414
Dr. Rajesh Sharma, M.d., Ph.d., M.b.a, M.D., PH.D., M.B.A
Neurology — Payments: $152,354
Dr. Patrick Weldon, M.d, M.D
Neurology — Payments: $75,924
Tiffany Scarff, M.d, M.D
Neurology — Payments: $50,276
Mitchell Myers, M.d, M.D
Neurology — Payments: $46,488